0 CHECKOUT

PRODUCT FILTERS

REGION

3
1
1
1
1

COUNTRY

1

CATEGORIES

  • 8
  • 6
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

0
1
2
29

PUBLISHED

0
0
24
29

PRODUCT TYPE

29

Search for: "Sareum Ltd-Therapeutic Competitors Report"

Gastric Cancer - Pipeline Review, H1 2015

Gastric Cancer - Pipeline Review, H1 2015 Summary: This, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline. This report provides...

Published:  March 2015
Price:  From

Neuroblastoma - Pipeline Review, H1 2015

Neuroblastoma - Pipeline Review, H1 2015 Summary This, ‘Neuroblastoma - Pipeline Review, H1 2015’, provides an overview of the Neuroblastoma’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Neuroblastoma - Pipeline Review, H2 2015

Neuroblastoma - Pipeline Review, H2 2015 Summary The report ‘Neuroblastoma - Pipeline Review, H2 2015’, provides an overview of the Neuroblastoma’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2015
Price:  From

Colon Cancer - Pipeline Review, H1 2015

Colon Cancer - Pipeline Review, H1 2015 Summary the, ‘Colon Cancer - Pipeline Review, H1 2015’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Multiple Sclerosis - Pipeline Review, H2 2015

Multiple Sclerosis - Pipeline Review, H2 2015 Summary The report ‘Multiple Sclerosis - Pipeline Review, H2 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

Multiple Sclerosis - Pipeline Review, H1 2015

Multiple Sclerosis - Pipeline Review, H1 2015 Summary the, ‘Multiple Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report provides...

Published:  June 2015
Price:  From

Head And Neck Cancer - Pipeline Review, H2 2015

Head And Neck Cancer - Pipeline Review, H2 2015 Summary The report ‘Head And Neck Cancer - Pipeline Review, H2 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline. This...

Published:  December 2015
Price:  From

Inflammatory Bowel Disease - Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Inflammatory Bowel Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

Published:  June 2015
Price:  From

Psoriasis - Pipeline Review, H2 2015

Psoriasis - Pipeline Review, H2 2015 Summary The report ‘Psoriasis - Pipeline Review, H2 2015’, provides an overview of the Psoriasis’s therapeutic pipeline. This report provides comprehensive information...

Published:  December 2015
Price:  From

Head And Neck Cancer - Pipeline Review, H1 2015

Head And Neck Cancer - Pipeline Review, H1 2015 Summary This, ‘Head And Neck Cancer - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline. This report...

Published:  January 2015
Price:  From

Prostate Cancer - Pipeline Review, H2 2015

Prostate Cancer - Pipeline Review, H2 2015 Summary The report ‘Prostate Cancer - Pipeline Review, H2 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline. This report provides...

Published:  December 2015
Price:  From

Colon Cancer - Pipeline Review, H2 2015

Colon Cancer - Pipeline Review, H2 2015 Summary The report ‘Colon Cancer - Pipeline Review, H2 2015’, provides an overview of the Colon Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2015
Price:  From

Non-Hodgkin Lymphoma - Pipeline Review, H2 2015

Non-Hodgkin Lymphoma - Pipeline Review, H2 2015 Summary The report ‘Non-Hodgkin Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline. This...

Published:  December 2015
Price:  From

Inflammatory Bowel Disease - Pipeline Review, H2 2015

Inflammatory Bowel Disease - Pipeline Review, H2 2015 Summary The report ‘Inflammatory Bowel Disease - Pipeline Review, H2 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic...

Published:  December 2015
Price:  From

Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Non-Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

Published:  June 2015
Price:  From

Breast Cancer - Pipeline Review, H1 2015

Breast Cancer - Pipeline Review, H1 2015 Summary This, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  January 2015
Price:  From

Gastric Cancer - Pipeline Review, H2 2015

Gastric Cancer - Pipeline Review, H2 2015 Summary The report ‘Gastric Cancer - Pipeline Review, H2 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  August 2015
Price:  From

Rheumatoid Arthritis - Pipeline Review, H2 2015

Rheumatoid Arthritis - Pipeline Review, H2 2015 Summary The report ‘Rheumatoid Arthritis - Pipeline Review, H2 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline. This...

Published:  December 2015
Price:  From

Pancreatic Cancer - Pipeline Review, H2 2015

Pancreatic Cancer - Pipeline Review, H2 2015 Summary The report ‘Pancreatic Cancer - Pipeline Review, H2 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline. This report provides...

Published:  December 2015
Price:  From

Rheumatoid Arthritis - Pipeline Review, H1 2015

Rheumatoid Arthritis - Pipeline Review, H1 2015 Summary the, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline. This report...

Published:  June 2015
Price:  From
Loading Indicator

Our Clients

  • Abbott Laboratories Ltd.
  • Ford Motor Company
  • Honeywell International, Inc.
  • Nike, Inc.
  • Deloitte LLP.
  • IMAX Corporation